Dr. Peter M. Anderson, MD, PhD

Dr. Anderson practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Anderson's NPI, 1033202825, was assigned on October 2, 2006. Dr. Anderson graduated from Icahn School Of Medicine At Mount Sinai in 1981. Dr. Anderson holds North Carolina license 26793.

Dr. Anderson's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Anderson's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Anderson to 2 more clinical labs and 1 medical group, each named with a free account. Dr. Anderson's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Anderson practices, 3 sites in all. Vendor and product names are available with a free account.

Pediatric hematology-oncology is Dr. Anderson's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Anderson is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Anderson's licenses on file in 13 states: North Carolina, Nevada, Ohio, Arizona, California, Iowa, Illinois, Minnesota, Pennsylvania, Tennessee, Texas, Colorado and Wisconsin.

Dmand AI lists asthma among the conditions Dr. Anderson treats.

CMS data shows 75 Medicare services from Dr. Anderson across 1 procedure code in 2021, all of them office visits, for 11 Medicare patients. Medicare paid $7,805 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 11 Medicare patients who saw Dr. Anderson in 2024. The largest group is 85 and over, with 0 patients. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Anderson's median patient age at 24, with 39% women.

In 2024, Dr. Anderson wrote 115 Medicare Part D claims for 14 patients. 74% of them were for generic drugs. CMS names the drug for 29 of them, across 2 drugs with 11 or more claims each, at $528,627 in total drug cost. In 2023, CMS named 75 claims across 5 drugs.

Dr. Anderson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Anderson as offering telehealth.

Dmand AI links 106 papers to Dr. Anderson, published from 2010 to 2024. 2020 was the busiest year, with 5. The most frequent topics are Interleukin-2, Bone Neoplasms and Osteosarcoma. Dr. Anderson has published most often in Clin Cancer Res. Dr. Anderson's most frequent co-authors are Emmanuel Katsanis, MD, Augusto C. Ochoa, MD and Carola Anne Sylvia Arndt, MD.

Dmand AI links Dr. Anderson to 5 clinical trials. Conditions studied include Osteosarcoma, Sarcoma, Ewing and Neoplasms, Bone Tissue.

CMS Open Payments shows 3 general payments to Dr. Anderson from 2 drug and device companies in 2022. Consulting fees make up the largest share, 95% of the total. Uswm, LLC paid the most, $2,491.

Dmand AI lists 2 awards for Dr. Anderson, most recently Top Doctors:SE Texas in 2013.

Dr. Anderson graduated from Icahn School Of Medicine At Mount Sinai in 1981. Dr. Anderson is a member of AOA, ASCO, ASH, ASPHO, CTOS and SIOP.

Dr. Anderson is in network with 16 carriers, including United Healthcare, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.